TABLE 3.

Adverse events

	Adverse Events, No.
	Totala		Emergency Departmentb		24-hour Follow-Up
Symptoms	Intranasal Ketorolac	Intravenous Ketorolac	Intranasal Ketorolac	Intravenous Ketorolac	Intranasal Ketorolac	Intravenous Ketorolac
Nausea	2	1	0	1	2	0
Dizziness	1	1	0	0	1	1
Sleepiness	0	1	0	1	0	0
Otherc	2	3	2	3	0	0
Total	5	6	2	5	3	1

^aFor the intranasal ketorolac group, 4 patients reported 5 adverse events. For the intravenous ketorolac group, 6 patients reported 6 events. Adverse events documented were not present prior to initial assessment at 60 min after study medication administration.

^bIncludes adverse events identified at 60 and 120 min after study medication administration.

^cOther includes “feeling cold”, “less focus, feel off”, transient extremity sensory complaints.